PARRY, ROMANI, DECONCINI & SYMMS for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Opposed efforts to preclude settlements in patent litigation. H.R. 3995, Protecting Consumer Access to Generic Drugs Act of 2012 S. 27, Preserve Access to Affordable Generics Act
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Economics/Economic Development ECN
General issues related to foreign direct investment in the United States, including all provisions of S. 3274 and H.R. 5910, Global Investment in American Jobs Act of 2012.
Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc., as disclosed on its LD-1.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Health Issues HCR
General issues related to prescription drug safety and the importation of prescription drugs. Opposed amendment to PDUFA, S. 3187, that would allow unsafe importation of drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act - including issues related to the Independent Payment Advisory Board. Issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine. H.R. 2405 and S.1855, Pandemic and All Hazards Preparation Act Reauthorization of 2011 - all provisions. H.R. 3627 and S.1884, School Access to Emergency Epinephrine Act - all provisions. Education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues. Education and awareness of Dengue. All provisions of H. Res. 295, Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Medicare/Medicaid MMM
Issues related to changes to the Medicare Part B reimbursement of prescription drugs; issues related to coverage and reimbursement issues for those who are covered by the Medicaid program and the Medicare program; including the Part D prescription drug benefit.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Medical/Disease Research/Clinical Labs MED
General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA), S. 3187 and H.R. 5651; and education and awareness of vaccine production and infrastructure needs.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.